INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹137 Cr | ₹99 Cr | ₹236 Cr | ₹286 Cr | ₹326 Cr |
What is the latest Operating Profit of INDOCO REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹137 Cr |
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹286 Cr |
| Mar2022 | ₹326 Cr |
How is Operating Profit of INDOCO REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹137 Cr | 38.22 | |
| Mar2025 | ₹99 Cr | -58.02 | |
| Mar2024 | ₹236 Cr | -17.35 | |
| Mar2023 | ₹286 Cr | -12.32 | |
| Mar2022 | ₹326 Cr | - | |
Compare Operating Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,107.2 Cr | 4.4% | -2.1% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 4.4% |
-2.1% |
-14.3% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses